Mu-opioid receptors facilitate the propagation of excitatory activity in rat hippocampal area CA1 by disinhibition of all anatomical layers

Journal of Neurophysiology

Volumn 90, Issue 3, 2003, Pages 1936-1948

  McQuiston, A Rory ^a   Saggau, Peter ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID B RECEPTOR BLOCKING AGENT; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; BENZYL[3 [[1 (3,4 DICHLOROPHENYL)ETHYL]AMINO] 2 HYDROXYPROPYL]PHOSPHINIC ACID; BICUCULLINE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; GLUTAMATE RECEPTOR ANTAGONIST; MU OPIATE RECEPTOR; NALOXONAZINE; NALOXONE; OPIATE;

ADDICTION; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CELL TYPE; CONTROLLED STUDY; DRUG DEPENDENCE; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPUS; INHIBITORY POSTSYNAPTIC POTENTIAL; INTERNEURON; MALE; MEMORY; NERVE CELL PLASTICITY; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; RAT;

ANIMALS; EXCITATORY POSTSYNAPTIC POTENTIALS; HIPPOCAMPUS; MALE; NEURAL INHIBITION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, MU;

EID: 0141453574     PISSN: 00223077     EISSN: None     Source Type: Journal    
DOI: 10.1152/jn.01150.2002     Document Type: Article

References (69)

1. Arvidsson U, Riedl M, Chakrabarti S, Lee JH, Nakano AH, Dado RJ, Loh HH, Law PY, Wessendorf ME, and Elde R. Distribution and targeting of a μ-opioid receptor (MOR1) in brain and spinal-cord. J Neurosci 15: 3328-3341, 1995.
2. Bausch SB and Chavkin C. Colocalization of mu and delta opioid receptors with GABA, parvalbumin, and a G-protein-coupled inwardly rectifying potassium channel (GIRK1) in the rodent brain. Analgesia 1: 282-285, 1995.
3. Capogna M, Gahwiler BH, and Thompson SM. Mechanism of mu-opioid receptor-mediated presynaptic inhibition in the rat hippocampus in-vitro. J Physiol 470: 539-558, 1993.
4. Cobb SR, Manuel NA, Morton RA, Gill CH, Collingridge GL, and Davies CH. Regulation of depolarizing GABA(A) receptor-mediated synaptic potentials by synaptic activation of GABA(B) autoreceptors in the rat hippocampus. Neuropharmacology 38: 1723-1732, 1999.
5. Cohen GA, Doze VA, and Madison DV. Opioid inhibition of GABA release from presynaptic terminals of rat hippocampal interneurons. Neuron 9: 325-335, 1992.
6. Colom LV and Saggau P. Spontaneous interictal-like activity originates in multiple areas of the CA2-CA3 region of hippocampal slices. J Neurophysiol 71: 1574-1584, 1994.
7. Corrigall WA and Linseman MA. A specific effect of morphine on evoked activity in the rat hippocampal slice. Brain Res 192: 227-238, 1980.
8. Corrigall WA and Linseman MA. Conditioned place preference produced by intra-hippocampal morphine. Pharmacol Biochem Behav 30: 787-789, 1988.
9. Crain BJ, Chang KJ, and McNamara JO. Quantitative autoradiographic analysis of mu and delta opioid binding sites in the rat hippocampal formation. J Comp Neurol 246: 170-180, 1986.
10. Deadwyler SA and Robinson JH. Effects of morphine on hippocampal cells recorded invitro. Brain Res Bull 4: 609-613, 1979.
11. Dingledine R. Possible mechanisms of enkephalin action on hippocampal CA1 pyramidal neurons. J Neurosci 1: 1022-1035, 1981.
12. Drake CT and Milner TA. Mu opioid receptors are in somatodendritic and axonal compartments of GABAergic neurons in rat hippocampal formation. Brain Res 849: 203-215, 1999.
13. Drake CT and Milner TA. Mu opioid receptors are in discrete hippocampal interneuron subpopulations. Hippocampus 12: 119-136, 2002.
14. Faulkner HJ, Traub RD, and Whittington MA. Disruption of synchronous gamma oscillations in the rat hippocampal slice: a common mechanism of anaesthetic drug action. Brit J Pharmacol 125: 483-492, 1998.
15. Faulkner HJ, Traub RD, and Whittington MA. Anaesthetic/amnesic agents disrupt beta frequency oscillations associated with potentiation of excitatory synaptic potentials in the rat hippocampal slice. Brit J Pharmacol 128: 1813-1825, 1999.
16. French ED and Siggins GR. An iontophoretic survey of opioid peptide actions in the rat limbic system - in search of opiate epileptogenic mechanisms. Regul Pept 1: 127-146, 1980.
17. Freund TF and Buzsaki G. Interneurons of the hippocampus. Hippocampus 6: 347-470, 1996.
18. 2+ channels in apical dendrites of rat CA1 pyramidal neurons. J Neurophysiol 77: 1639-1643, 1997.
19. A receptor-mediated responses in pyramidal cells of rat hippocampus. J Neurophysiol 69: 1541-1555, 1993.
20. Haas HL and Ryall RW. Is excitation by enkephalins of hippocampal-neurons in the rat due to presynaptic facilitation or to disinhibition? J Physiol 308: 315-330, 1980.
21. Hausser M, Spruston N, and Stuart GJ. Diversity and dynamics of dendritic signaling. Science 290: 739-744, 2000.
22. Jin W, Zhang RJ, and Wu JY. Voltage-sensitive dye imaging of population neuronal activity in cortical tissue. J Neurosci Methods 115: 13-27, 2002.
23. A receptor-mediated dendritic inhibition in area CA1 of the rat hippocampus. J Neurophysiol 66: 1538-1548, 1991.
24. Lambert NA, Harrison NL, and Teyler TJ. Evidence for μ-opiate receptors on inhibitory terminals in area CA1 of rat hippocampus. Neurosci Lett 124: 101-104, 1991.
25. Lee HK, Dunwiddie T, and Hoffer B. Electro-physiological interactions of enkephalins with neuronal circuitry in the rat hippocampus. 2. Effects on interneuron excitability. Brain Res 184: 331-342, 1980.
26. + channels amplify EPSPs in hippocampal CA1 pyramidal cells. J Neurophysiol 76: 2181-2191, 1996.
27. Lupica CR. Delta-enkephalin and mu-enkephalin inhibit spontaneous GABA-mediated IPSCs via a cyclic-AMP-independent mechanism in the rat hippocampus. J Neurosci 15: 737-749, 1995.
28. Lupica CR, Proctor WR, and Dunwiddie TV. Dissociation of mu-opioid and delta-opioid receptor-mediated reductions in evoked and spontaneous synaptic inhibition in the rat hippocampus in vitro. Brain Res 593: 226-238, 1992.
29. Lynch GS, Jensen RA, McGaugh JL, Davila K, and Oliver MW. Effects of enkephalin, morphine, and naloxone on the electrical-activity of the in vitro hippocampal slice preparation. Exp Neurol 71: 527-540, 1981.
30. Madison DV and Nicoll RA. Enkephalin hyperpolarizes interneurones in the rat hippocampus. J Physiol 398: 123-130, 1988.
31. Magee J, Hoffman D, Colbert C, and Johnston D. Electrical and calcium signaling in dendrites of hippocampal pyramidal neurons. Annu Rev Physiol 60: 327-346, 1998.
32. Magee JC. Dendritic integration of excitatory synaptic input. Nature Rev Neurosci 1: 181-190, 2000.
33. Mansour A, Fox CA, Burke S, Akil H, and Watson SJ. Immunohistochemical localization of the cloned mu-opioid receptor in the rat CNS. J Chem Neuroanat 8: 283-305, 1995.
34. Mansour A, Khachaturian H, Lewis ME, Akil H, and Watson SJ. Auto-radiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. J Neurosci 7: 2445-2464, 1987.
35. Mansouri FA, Motamedi F, and Fathollahi Y. Chronic in vivo morphine administration facilitates primed- bursts-induced long-term potentiation of Schaffer collateral-CA1 synapses in hippocampal slices in vitro. Brain Res 815: 419-423, 1999.
36. Mansouri FA, Motamedi F, Fathollahi Y, Atapour N, and Semnanian S. Augmentation of LTP induced by Primed-Bursts tetanic stimulation in hippocampal CA1 area of morphine dependent rats. Brain Res 769: 119-124, 1997.
37. Martinez JL Jr, Jensen RA, Creager R, Veliquette J, Messing RB, McGaugh JL, and Lynch G. Selective effects of enkephalin on electrical activity of the in vitro hippocampal slice. Behav Neural Biol 26: 128-131, 1979.
38. Masukawa LM and Prince DA. Enkephalin inhibition of inhibitory input to CA1 and CA3 pyramidal neurons in the hippocampus. Brain Res 249: 271-280, 1982.
39. Matthes HWD, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, Befort K, Dierich A, LeMeur M, Dolle P, Tzavara E, Hanoune J, Roques BP, and Kieffer BL. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383: 819-823, 1996.
40. McLean S, Rothman RB, Jacobson AE, Rice KC, and Herkenham M. Distribution of opiate receptor subtypes and enkephalin and dynorphin immunoreactivity in the hippocampus of squirrel, guinea pig, rat, and hamster. J Comp Neurol 255: 497-510, 1987.
41. A receptors in the hippocampus. Science 253: 1420-1423, 1991.
42. Miles R, Toth K, Gulyas AI, Hajos N, and Freund TF. Differences between somatic and dendritic inhibition in the hippocampus. Neuron 16: 815-823, 1996.
43. Negus SS, Henriksen SJ, Mattox A, Pasternak GW, Portoghese PS, Takemori AE, Weinger MB, and Koob GF. Effect of antagonists selective for mu-opioid, delta-opioid and kappa-opioid receptors on the reinforcing effects of heroin in rats. J Pharmacol Exp Ther 265: 1245-1252, 1993.
44. Neumaier JF, Mailheau S, and Chavkin C. Opioid receptor-mediated responses in the dentate gyrus and CA1 region of the rat hippocampus. J Pharmacol Exp Ther 244: 564-570, 1988.
45. Nicoll RA, Alger BE, and Jahr CE. Enkephalin blocks inhibitory pathways in the vertebrate CNS. Nature 287: 22-25, 1980.
46. Olmstead MC and Franklin KBJ. The development of a conditioned place preference to morphine: effects of lesions of various CNS sites. Behav Neurosci 111: 1313-1323, 1997a.
47. Olmstead MC and Franklin KBJ. The development of a conditioned place preference to morphine: Effects of microinjections into various CNS sites. Behav Neurosci 111: 1324-1334, 1997b.
48. Pang K and Rose GM. Differential-effects of methionine-5-enkephalin on hippocampal pyramidal cells and interneurons. Neuropharmacology 28: 1175-1181, 1989.
49. Perkins KL. Cl- accumulation does not account for the depolarizing phase of the synaptic GABA response in hippocampal pyramidal cells. J Neurophysiol 82: 768-777, 1999.
50. Perkins KL and Wong RK. Ionic basis of the postsynaptic depolarizing GABA response in hippocampal pyramidal cells. J Neurophysiol 76: 3886-3894, 1996.
51. Pu L, Bao GB, Xu NJ, Ma L, and Pei G. Hippocampal long-term potentiation is reduced by chronic opiate treatment and can be restored by re-exposure to opiates. J Neurosci 22: 1914-1921, 2002.
52. Rekling JC. Effects of met-enkephalin on GABAergic spontaneous miniature IPSPS in organotypic slice cultures of the rat hippocampus. J Neurosci 13: 1954-1964, 1993.
53. Reyes A. Influence of dendritic conductances on the input-output properties of neurons. Annu Rev Neurosci 24: 653-675, 2001.
54. Robinson JH and Deadwyler SA. Intracellular correlates of morphine excitation in the hippocampal slice preparation. Brain Res 224: 375-387, 1981.
55. Self DW and Stein L. Pertussis toxin attenuates intracranial morphine self-administration. Pharmacol Biochem Behav 46: 689-695, 1993.
56. Siggins GR and Zieglgansberger W. Morphine and opioid-peptides reduce inhibitory synaptic potentials in hippocampal pyramidal cells-in vitro without alteration of membrane-potential. Proc Nat Acad Sci USA 78: 5235-5239, 1981.
57. Sinha SR, Patel SS, and Saggau P. Simultaneous optical-recording of evoked and spontaneous transients of membrane-potential and intracellular calcium-concentration with high spatiotemporal resolution. J Neurosci Methods 60: 49-60, 1995.
58. Sinha SR and Saggau P. Optical recording from populations of neurons in brain slices. In: Modern Techniques in Neuroscience Research, edited by Johanson H and Windhorst U. Heidelberg, Germany: Springer Verlag, 1999.
59. Staley KJ, Soldo BL, and Proctor WR. Ionic mechanisms of neuronal excitation by inhibitory GABAA receptors. Science 269: 977-981, 1995.
60. Stevens KE, Shiotsu G, and Stein L. Hippocampal mu-receptors mediate opioid reinforcement in the CA3 region. Brain Res 545: 8-16, 1991.
61. Svoboda KR, Adams CE, and Lupica CR. Opioid receptor subtype expression defines morphologically distinct classes of hippocampal interneurons. J Neurosci 19: 85-95, 1999.
62. Svoboda KR and Lupica CR. Opioid inhibition of hippocampal interneurons via modulation of potassium and hyperpolarization-activated cation (Ih) currents. J Neurosci 18: 7084-7098, 1998.
63. Swearengen E and Chavkin C. Comparison of opioid and GABA receptor control of excitability and membrane conductance in hippocampal CA1 pyramidal cells in rat. Neuropharmacology 28: 689-697, 1989.
64. Taira T, Lamsa K, and Kaila K. Posttetanic excitation mediated by GABA(A) receptors in rat CA1 pyramidal neurons. J Neurophysiol 77: 2213-2218, 1997.
65. Wagner JJ, Etemad LR, and Thompson AM. Opioid-mediated facilitation of long-term depression in rat hippocampus. J Pharmacol Exp Ther 296: 776-781, 2001.
66. Whittington MA, Traub RD, Faulkner HJ, Jefferys JGR, and Chettiar K. Morphine disrupts long-range synchrony of gamma oscillations in hippocampal slices. Proc Natl Acad Sci USA 95: 5807-5811, 1998.
67. Wimpey TL and Chavkin C. Opioids activate both an inward rectifier and a novel voltage- gated potassium conductance in the hippocampal-formation. Neuron 6: 281-289, 1991.
68. Zieglgansberger W, French ED, Siggins GR, and Bloom FE. Opioid peptides may excite hippocampal pyramidal neurons by inhibiting adjacent inhibitory interneurons. Science 205: 415-417, 1979.
69. Zochowski M, Wachowiak M, Falk CX, Cohen LB, Lam YW, Antic S, and Zecevic D. Imaging membrane potential with voltage-sensitive dyes. Biol Bull 198: 1-21, 2000.